• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新提出的高级别模式百分比与病理T1-2N0M0肺腺癌的预后相关。

Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma.

作者信息

Wang Yaqi, Yang Xin, Liu Bing, Yan Shi, Liu Mengfei, Li Xiang, Li Shaolei, Lv Chao, Ma Yuanyuan, Zhou Lixin, Song Zhijie, Xv Wantong, Yang Yue, Lin Dongmei, Wu Nan

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital and Institute, Beijing, 100142, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, 100142, China.

出版信息

Ann Surg Oncol. 2022 Feb 24. doi: 10.1245/s10434-022-11444-0.

DOI:10.1245/s10434-022-11444-0
PMID:35211858
Abstract

OBJECTIVE

To evaluate the prognostic value of the percentage of high-grade patterns (micropapillary, solid, and complex glands) in early-stage lung adenocarcinoma (LUAD).

METHODS

A total of 1049 patients undergoing radical surgery with pathological T1-2N0M0 LUAD were screened retrospectively, and 191 patients were involved in the final analysis. Disease-free survival (DFS) was evaluated using the Kaplan-Meier curve and Cox regression analysis. The optimal cut-off value was determined using maximally selected rank statistics.

RESULTS

The entire cohort was divided into quartile groups based on the percentage of high-grade patterns: Group 1 (≤ 30%), Group 2 (31-55%), Group 3 (56-85%), and Group 4 (≥ 86%). There were significant differences in smoking history (P = 0.041), EGFR mutations (P < 0.001), and ALK rearrangement (P = 0.010) between the four groups, but no significant differences in other clinicopathological features. Kaplan-Meier analysis showed that a higher percentage of high-grade patterns predicted worse DFS (P = 0.001), and multivariate analysis indicated that the percentage of high-grade patterns was an independent predictor (Group 2 vs. Group 1, HR = 2.136, P = 0.228; Group 3 vs. Group 1, HR = 3.355, P = 0.035; Group 4 vs. Group 1, HR = 5.147, P = 0.003, respectively). A cut-off value of 20% (P = 0.048) and 50% (P <0.001) for high-grade patterns were tested, and both revealed a significant difference in distinguishing DFS between subgroups.

CONCLUSIONS

The percentage of high-grade patterns is associated with the prognosis of early-stage invasive LUAD. A higher percentage indicates a worse prognosis.

摘要

目的

评估高级别模式(微乳头、实性和复杂腺体)百分比在早期肺腺癌(LUAD)中的预后价值。

方法

回顾性筛选1049例行根治性手术的病理T1-2N0M0期LUAD患者,191例患者纳入最终分析。采用Kaplan-Meier曲线和Cox回归分析评估无病生存期(DFS)。使用最大选择秩统计量确定最佳截断值。

结果

根据高级别模式百分比将整个队列分为四分位组:第1组(≤30%)、第2组(31-55%)、第3组(56-85%)和第4组(≥86%)。四组之间吸烟史(P = 0.041)、表皮生长因子受体(EGFR)突变(P < 0.001)及间变性淋巴瘤激酶(ALK)重排(P = 0.010)存在显著差异,但在其他临床病理特征方面无显著差异。Kaplan-Meier分析显示,高级别模式百分比越高,DFS越差(P = 0.001),多因素分析表明高级别模式百分比是独立预测因素(第2组与第1组相比,风险比[HR] = 2.136,P = 0.228;第3组与第1组相比,HR = 3.355,P = 0.035;第4组与第1组相比,HR = 5.147,P = 0.003)。对高级别模式百分比的截断值20%(P = 0.048)和50%(P <0.001)进行检验,二者均显示在区分亚组DFS方面存在显著差异。

结论

高级别模式百分比与早期浸润性LUAD的预后相关。百分比越高,预后越差。

相似文献

1
Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma.新提出的高级别模式百分比与病理T1-2N0M0肺腺癌的预后相关。
Ann Surg Oncol. 2022 Feb 24. doi: 10.1245/s10434-022-11444-0.
2
Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study.肺腺癌中第二主要亚型的预后:一项回顾性单中心队列研究
J Thorac Dis. 2022 Dec;14(12):4846-4864. doi: 10.21037/jtd-22-1524.
3
Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.I 期肺腺癌高级别模式之间临床结果的比较。
Thorac Cancer. 2022 Sep;13(17):2473-2479. doi: 10.1111/1759-7714.14578. Epub 2022 Jul 12.
4
[Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].[术前外周血淋巴细胞与单核细胞比值对Ⅲ期结肠癌患者预后的评估价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):73-78.
5
Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma.肺腺癌从癌前病变到浸润性腺癌的演变。
Cancer Med. 2023 Mar;12(5):5545-5557. doi: 10.1002/cam4.5393. Epub 2022 Nov 3.
6
[Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].食管胃交界腺癌与胃窦腺癌临床病理特征及预后的比较
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):149-155.
7
Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.伴有非主要微乳头成分的IA期肺腺癌患者术后辅助化疗的预后意义及生存获益
World J Surg Oncol. 2024 Jan 25;22(1):32. doi: 10.1186/s12957-024-03303-x.
8
[Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer].[术前淋巴细胞与单核细胞比值预测T1期非肌层浸润性膀胱癌患者的预后]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Oct 30;41(5):622-629. doi: 10.3881/j.issn.1000-503X.11227.
9
Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis.早期肺腺癌中高级别模式的影响:一项多中心分析。
Lung. 2022 Oct;200(5):649-660. doi: 10.1007/s00408-022-00561-y. Epub 2022 Aug 21.
10
[Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].[Ⅰ期肺腺癌病理分期预后价值的验证]
Zhonghua Wai Ke Za Zhi. 2022 Jun 1;60(6):580-586. doi: 10.3760/cma.j.cn112139-20211008-00474.

引用本文的文献

1
Clinicopathological factors . molecular model for predicting adjuvant EGFR-TKI benefit in stage I EGFR-mutant non-small cell lung cancer.临床病理因素。预测I期表皮生长因子受体(EGFR)突变型非小细胞肺癌辅助性EGFR酪氨酸激酶抑制剂(TKI)疗效的分子模型。
Transl Lung Cancer Res. 2025 May 30;14(5):1531-1542. doi: 10.21037/tlcr-2025-20. Epub 2025 May 26.
2
A nomogram predicts the new high-grade patterns of pulmonary invasive non-mucinous adenocarcinoma based on the radiomics and clinical features.一种列线图基于影像组学和临床特征预测肺浸润性非黏液腺癌的新高级别模式。
Am J Transl Res. 2025 Feb 15;17(2):941-950. doi: 10.62347/IHZB9566. eCollection 2025.
3

本文引用的文献

1
Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study.I期肺腺癌中肿瘤通过气腔播散能否从辅助化疗中获益?一项多机构研究。
Ther Adv Med Oncol. 2020 Dec 14;12:1758835920978147. doi: 10.1177/1758835920978147. eCollection 2020.
2
Long-term survival outcomes of video-assisted thoracic surgery for patients with non-small cell lung cancer.电视辅助胸腔镜手术治疗非小细胞肺癌患者的长期生存结果。
Chin J Cancer Res. 2014 Aug;26(4):391-8. doi: 10.3978/j.issn.1000-9604.2014.08.04.
The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity.
微乳头和/或实体亚型的存在是接受I期磨玻璃影肺腺癌根治性切除患者的独立预后因素。
Transl Lung Cancer Res. 2024 Feb 29;13(2):256-268. doi: 10.21037/tlcr-23-736. Epub 2024 Feb 20.
4
A pretreatment prediction model of grade 3 tumors classed by the IASLC grading system in lung adenocarcinoma.肺腺癌 IASLC 分级系统中 3 级肿瘤的预处理预测模型。
BMC Pulm Med. 2023 Oct 7;23(1):377. doi: 10.1186/s12890-023-02690-3.
5
[A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma].[ⅠA期肺腺癌的病理高危因素及术后辅助化疗综述]
Zhongguo Fei Ai Za Zhi. 2022 Aug 20;25(8):593-600. doi: 10.3779/j.issn.1009-3419.2022.101.30.